Takahiro Ochiya,
Professor,
Department of Molecular and Cellular Medicine, Tokyo Medical University
Dr. Takahiro Ochiya was a Chief of Division of Molecular and Cellular Medicine at the National Cancer Center Research Institute, Tokyo since 2011 and he is currently appointed as professor of Tokyo Medical University (since 2018). After he got Ph.D. in 1988 in Osaka University and then went to do a post-doc at La Jolla Cancer Research (Burnham Institute for Medical Research), CA, USA. Dr. Ochiya’s lab focuses the development of novel animal models, methods, and strategies to study cancer development and metastasis. Especially, current focuses are siRNA- and microRNA-based therapy against cancer stem cells. Dr. Ochiya is one of top scientist in Exosome research in cancer area and carries President of Japanese Society of Extracellular Vesicles (JSEV) since 2014.
Early Detection of Cancer by Serum Exosomes
Wednesday, 24 October 2018 at 14:00
Add to Calendar ▼2018-10-24 14:00:002018-10-24 15:00:00Europe/LondonEarly Detection of Cancer by Serum ExosomesExosomes and Liquid Biopsies Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Recent studies have revealed a novel biomolecule, the exosome, which supports cancer metastasis and many other cancer–associated events. Exosomes are a subset of extracellular vesicles (EVs), which are lipid bilayer vesicles secreted from cells. Exosomes have a diameter of 50–150 nm, and they transfer miRNA, mRNA, DNA, and proteins to other cells, thereby mediating intercellular communications. Application of these EVs for biomarker analysis, biofunctions and cell-free regeneration medicine are actively studied, however, common methods for EVs isolation is not always accurately conducted. Especially, EVs represent an important source of potential biomarkers in many diseases that could provide a non-invasive method of early diagnosis or prognosis. Here we will discuss on our current progress on EVs detection as ExoScreen method (Yoshioka et al., Nat Commun, 2014) and usage for early detection of colorectal and pancreatic cancer with high sensitivity and specificity.
Add to Calendar ▼2018-10-24 00:00:002018-10-26 00:00:00Europe/LondonExosomes and Liquid Biopsies Europe 2018Exosomes and Liquid Biopsies Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2018-10-24 14:00:002018-10-24 15:00:00Europe/LondonEarly Detection of Cancer by Serum ExosomesExosomes and Liquid Biopsies Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
